Hematology-Oncology Associates Of Central New York, P.C. 401(K) Plan — Form 5500 plan (Hematology-Oncology Associates Of Central New York, P.C.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Hematology-Oncology Associates Of Central New York, P.C. 401(K) Plan is a benefit plan reported by Hematology-Oncology Associates Of Central New York, P.C. under EIN 16-1184100 and plan number 002. The latest loaded filing year is 2023. The filing reports 462 participants and $63,617,228 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Hematology-Oncology Associates Of Central New York, P.C.
EIN
16-1184100
Plan number
002
Plan type
2
Location
East Syracuse, NY
Latest filing year
2023
Participants
462
End-of-year plan assets
$63,617,228

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023462H, C20241007121113NAL0031684274001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$63,617,228
Total liabilities (EOY)
$0
Net assets (EOY)
$63,617,228
Net assets (BOY)
$54,384,392

Income & contributions

Employer contributions
$1,900,094
Participant contributions
$2,347,931
Total contributions
$4,407,665
Total income / additions
$11,114,184

Expenses & distributions

Benefits paid
$1,838,981
Administrative expenses
$33,747
Total expenses
$1,881,348
Net increase / (decrease)
$9,232,836

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Hnp Capital, LLCNONE$13,140not reported in the loaded dataset2023
The Vanguard Group, Inc.NONE$12,839$02023
Courier Capital.NONE$6,708not reported in the loaded dataset2023

Related Form 5500 pages